Keros Therapeutics (KROS) - Net earnings per share (EPS TTM)

Symbol and logo of brand kerostx.com (KROS)

Keros Therapeutics (KROS) is developing an advanced treatment system for blood pathologies, establishing new industry standards. Comparing the rolling annual earnings per share trend on GURU.Markets, we see that the -2.85 level indicates the status of the parameter. Keros Therapeutics reduces capital risks through a diverse pipeline of biologics for musculoskeletal and hematological diseases. However, the absence of commercial sales and rising trial costs necessitate continuous external financing.

KROS (kerostx.com) Earnings per share for the last 12 months history from 07/04/2022 to 11/18/2026

Comprehensive metric breakdowns and analytics for Keros Pharma (KROS)

- share price and expert price forecast:
General company analysis:kerostx.com (KROS)
Mass-produced product of Keros Therapeutics Inc

Keros Therapeutics (KROS) minimizes operational risks by outsourcing drug development and clinical trials to third-party contractors. This rolling annual earnings per share chart reflects the ultimate effectiveness of this strategy, converting the aggregate net result into per-share income to assess the real return on capital and the fundamental value of asset ownership.

Competitors of Keros Therapeutics (KROS)

VRTX: Net earnings per share for the last 12 months|Earnings per one share for the last 12 months ALNY|INSM: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months United Therapeutics Corp. (UTHR)|BMRN (BioMarin) - Net earnings per share (EPS TTM)|Earnings per share for the last 12 months BBIO (BridgeBio)|Earnings per share for the last twelve months bgm.ltd (BGM)|COGT (Cogent Biosciences Inc) - Earnings per share for the trailing year|Earnings per share for the last twelve months Xeris Biopharma Holdings XERS|ARCT (Arcturus Pharma) - Earnings per one share for the last 12 months|Eton Pharmaceuticals - Net earnings per share (EPS TTM)|Earnings per share for the trailing year KMDA (Kamada Ltd.)|FULC: Net earnings per share (EPS TTM)|Abeona (ABEO) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months mereobiopharma.com|Net earnings per share for the last 12 months Protalix (PLX)|Earnings per share for the last twelve months Pliant Therapeutics Inc (PLRX)|Net earnings per share for the last 12 months Applied Therapeutics, Inc. APLT|Net earnings per share (EPS TTM) RNTX (aileronrx.com)|Net earnings per share (EPS TTM) Gelteq Limited Inc GELS|Aytu BioPharma, Inc. - Net earnings per share (EPS TTM)|chemomab.com (CMMB) - Net earnings per share for the last 12 months|SRx Health (SRXH) - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Polyrizon Ltd. (PLRZ)|Net earnings per share for the last 12 months AEZS|Net earnings per share for the last 12 months Cyclo Therapeutics Inc. (CYTH)|Net earnings per share for the last 12 months INZY (inozyme.com)|RPHM - Net earnings per one share for the last twelve months|Net earnings per share (EPS TTM) CSCI (cosciensbio.com)